U.S. Markets close in 59 mins
  • S&P 500

    4,582.53
    +15.53 (+0.34%)
     
  • Dow 30

    34,495.91
    +12.19 (+0.04%)
     
  • Nasdaq

    15,495.20
    -42.49 (-0.27%)
     
  • Russell 2000

    2,189.24
    -9.67 (-0.44%)
     
  • Crude Oil

    65.95
    -0.23 (-0.35%)
     
  • Gold

    1,782.40
    +5.90 (+0.33%)
     
  • Silver

    22.32
    -0.50 (-2.19%)
     
  • EUR/USD

    1.1321
    -0.0018 (-0.1585%)
     
  • 10-Yr Bond

    1.4460
    +0.0030 (+0.21%)
     
  • Vix

    26.47
    -0.72 (-2.65%)
     
  • GBP/USD

    1.3280
    -0.0021 (-0.1594%)
     
  • USD/JPY

    112.8140
    -0.3660 (-0.3234%)
     
  • BTC-USD

    57,460.32
    -170.31 (-0.30%)
     
  • CMC Crypto 200

    1,468.50
    -0.58 (-0.04%)
     
  • FTSE 100

    7,168.68
    +109.23 (+1.55%)
     
  • Nikkei 225

    27,935.62
    +113.86 (+0.41%)
     

How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings

·3 min read

Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the metrics and results to consider, earnings is one of the most important.

Life and the stock market are both about expectations, and rising above what is expected is often rewarded, while falling short can come with negative consequences. Investors might want to try to capture stronger returns by finding positive earnings surprises.

The ability to identify stocks that are likely to top quarterly earnings expectations can be profitable, but it's no simple task. Here at Zacks, our Earnings ESP filter helps make things easier.

The Zacks Earnings ESP, Explained

The Zacks Earnings ESP, or Expected Surprise Prediction, aims to find earnings surprises by focusing on the most recent analyst revisions. The basic premise is that if an analyst reevaluates their earnings estimate ahead of an earnings release, it means they likely have new information that could possibly be more accurate.

With this in mind, the Expected Surprise Prediction compares the Most Accurate Estimate (being the most recent) against the overall Zacks Consensus Estimate. The percentage difference provides the ESP figure. The system also utilizes our core Zacks Rank to provide a stronger system for identifying stocks that might beat their next quarterly earnings estimate and possibly see the stock price climb.

In fact, when we combined a Zacks Rank #3 (Hold) or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time. Perhaps most importantly, using these parameters has helped produce 28.3% annual returns on average, according to our 10 year backtest.

Stocks with a #3 (Hold) ranking, which is most stocks covered at 60%, are expected to perform in-line with the broader market. But stocks that fall into the #2 (Buy) and #1 (Strong Buy) ranking, or the top 15% and top 5% of stocks, respectively, should outperform the market. Strong Buy stocks should outperform more than any other rank.

Should You Consider Medifast?

Now that we understand what the ESP is and how beneficial it can be, let's dive into a stock that currently fits the bill. Medifast (MED) earns a #1 (Strong Buy) right now and its Most Accurate Estimate sits at $3.51 a share, just 30 days from its upcoming earnings release on August 4, 2021.

Medifast's Earnings ESP sits at 6.85%, which, as explained above, is calculated by taking the percentage difference between the $3.51 Most Accurate Estimate and the Zacks Consensus Estimate of $3.29. MED is also part of a large group of stocks that boast a positive ESP. All of these qualifying stocks can be filtered by ESP, Zacks Rank, % Surprise (Last Qtr.), and Reporting date.

Now that you know how to use the Zacks Earnings ESP to your advantage, make sure to check out the Earnings ESP Home Page for even more earnings related strategies to create a winning portfolio.

Find Stocks to Buy or Sell Before They're Reported

Use the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
MEDIFAST INC (MED) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.